Prospective, Multicentre, Open Label, Non-Controlled, 24-Week Observation in Type 2 Diabetics Using Once Daily Levemir (Insulin Detemir) as Part of Their ITT Regimen.
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LITHULEV1
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 24 Nov 2010 Actual end date changed from Jan 2010 to Dec 2009 as reported by ClinicalTrials.gov.
- 25 Mar 2010 Actual end date changed from Dec 2009 to Jan 2010 as reported by ClinicalTrials.gov.